These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
122 related items for PubMed ID: 8125348
1. Friedan and estrogen: 'most unfortunate that she is so misinformed'. Meisner LF, Schinitsky MR. Geriatrics; 1994 Mar; 49(3):11. PubMed ID: 8125348 [No Abstract] [Full Text] [Related]
2. [Menopause and hormone therapy]. Rüedi B. Rev Med Suisse Romande; 1989 Nov; 109(11):885-7. PubMed ID: 2595161 [No Abstract] [Full Text] [Related]
3. Hormone replacement therapy: benefits and risks for the general postmenopausal female population and for women with a history of previously treated breast cancer. Bluming AZ. Semin Oncol; 1993 Dec; 20(6):662-74. PubMed ID: 8296203 [No Abstract] [Full Text] [Related]
4. [Prevention of osteoporosis by estrogens]. Birkhäuser M. Rev Med Suisse Romande; 1995 Feb; 115(2):113-20. PubMed ID: 7886365 [No Abstract] [Full Text] [Related]
5. [Estrogen substitution following the menopause and the risk of breast cancer; the importance of endogenous risk factors]. Russchen CJ. Ned Tijdschr Geneeskd; 1992 Jul 11; 136(28):1337-9. PubMed ID: 1635595 [No Abstract] [Full Text] [Related]
6. Postmenopausal estrogen therapy and cardiovascular disease. Fleming BJ. N Engl J Med; 1992 Mar 05; 326(10):705; author reply 707. PubMed ID: 1736111 [No Abstract] [Full Text] [Related]
7. Hormone replacement therapy. Reid IR. N Z Med J; 1994 Apr 13; 107(975):138. PubMed ID: 8145969 [No Abstract] [Full Text] [Related]
8. [Breast carcinoma and later hormonal osteoporosis prevention]. Obrecht JP. Dtsch Med Wochenschr; 1992 Oct 16; 117(42):1615-6. PubMed ID: 1396160 [No Abstract] [Full Text] [Related]
9. [Hormone replacement therapy and breast cancer--any news?]. Holli K. Duodecim; 1999 Oct 16; 115(2):101-2. PubMed ID: 11830839 [No Abstract] [Full Text] [Related]
10. Is hormone replacement therapy a risk? Davidson NE. Sci Am; 1996 Sep 16; 275(3):101. PubMed ID: 8701274 [No Abstract] [Full Text] [Related]
11. [Various practical schemes of substitution hormone therapy]. Gaspard U. Rev Med Liege; 1994 Apr 16; 49(4):182-9. PubMed ID: 8209120 [No Abstract] [Full Text] [Related]
12. Weighing the risks and benefits of hormone therapy. Toth S, Blanchard E, Herman L, Larson L, Léger MM, McNellis R, Quigley T, Van Dyke E. JAAPA; 2003 Jun 16; 16(6):45-7. PubMed ID: 14968505 [No Abstract] [Full Text] [Related]
13. Hold the hormones? The good and the bad about postmenopausal estrogen therapy. Nemecek S. Sci Am; 1997 Sep 16; 277(3):38, 40. PubMed ID: 9304196 [No Abstract] [Full Text] [Related]
14. Is there sufficient evidence for us to encourage the widespread use of hormone replacement therapy to prevent disease? Hannaford PC. Br J Gen Pract; 1998 Feb 16; 48(427):951-2. PubMed ID: 9624761 [No Abstract] [Full Text] [Related]
15. Raloxifene and prevention of vertebral fracture (cont'd): mainly when oestrogen is contraindicated. Prescrire Int; 2000 Dec 16; 9(50):190-1. PubMed ID: 11475503 [Abstract] [Full Text] [Related]
16. Menopausal hormone replacement therapy and risk of breast cancer. Implications for the treatment of osteoporosis in postmenopausal women. Lopes P. Rev Rhum Engl Ed; 1996 May 16; 63(5):309-11. PubMed ID: 8789875 [No Abstract] [Full Text] [Related]
18. [Menopause in women--hormonal replacement therapy]. Kulikowski M, Tomaszewska I. Pol Tyg Lek; 1995 Nov 16; 50(44-47):5-9. PubMed ID: 8643429 [No Abstract] [Full Text] [Related]
19. [Effects of estrogen and selective estrogen receptor modulators on osteoporosis]. Urano T. Clin Calcium; 2005 Apr 16; 15(4):591-5. PubMed ID: 15802770 [Abstract] [Full Text] [Related]
20. Health risks after cessation of postmenopausal hormone therapy. Pines A, Sturdee D, Birkhäuser M, International Menopause Society. Climacteric; 2008 Jun 16; 11(3):179-80. PubMed ID: 18568782 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]